Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral vs Intravenous Antibiotics for Treatment of Periprosthetic Joint Infection
NCT04723940Phase 3Enrolling by invitation
- Sponsor
- Rothman Orthopaedics
- Start
- Jan 2021
- Primary completion
- Jan 2028
- Countries
- 1
01
Overview
A Phase 3 trial of trimethoprim + sulfamethoxazole, cefadroxil, doxycycline, clindamycin in periprosthetic joint infection (PJI), sponsored by Rothman Orthopaedics. Started Jan 2021; status: enrolling by invitation.
02
Drugs
trimethoprim + sulfamethoxazolecefadroxildoxycyclineclindamycin
03
Conditions
periprosthetic joint infection (PJI)
Beyond the preview
Go deeper on NCT04723940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04723940.